Cancer Urology

Онкоурология

1726-97761996-1812

Publishing House ABV Press

10.17650/1726-9776-2010-6-1-80-84

CLINICAL CASE

КЛИНИЧЕСКИЙ СЛУЧАЙ

ОПЫТ ПРИМЕНЕНИЯ ПРЕПАРАТА СУТЕНТ У БОЛЬНЫХ МЕТАСТАТИЧЕСКИМ ПОЧЕЧНО-КЛЕТОЧНЫМ РАКОМ: ОТДАЛЕННЫЕ РЕЗУЛЬТАТЫ ЛЕЧЕНИЯ

Харкевич

Г. Ю.

Russian Federation

gkharkevich@mail.ruСинельников

И. Е.

Russian Federation

gkharkevich@mail.ruБуйденок

В. Ю.

Russian Federation

gkharkevich@mail.ruСамойленко

И. В.

Russian Federation

gkharkevich@mail.ruДемидов

Л. В.

Russian Federation

gkharkevich@mail.ru

ГУ РОНЦ им. Н.Н. Блохина РАМН, Москва

30032010

80842407201424072014

https://oncourology.abvpress.ru/oncur/article/view/38

Случай из практики

1. Gore M.T., Szczylik C., Porta C. et al. Safety and efficacy of sunitinib for metastatic renal-cell carcinoma: an expandedaccess trial. Lancet Oncol 2009;10:757-63.

Gore M.T., Szczylik C., Porta C. et al. Safety and efficacy of sunitinib for metastatic renal-cell carcinoma: an expandedaccess trial. Lancet Oncol 2009;10:757-63.

2. Faivre S., Demetri G., Sargent W. et al. Molecular basis for sunitinib efficacy and future clinical development. Natur Rev 2007;6:734-44.

Faivre S., Demetri G., Sargent W. et al. Molecular basis for sunitinib efficacy and future clinical development. Natur Rev 2007;6:734-44.

3. Motzer R.J., Hutson T.E., Tomczak P. et al. Sunitinib versus Interferon alfa in metastatic renal-cell carcinoma. N Engl J Med 2007;356:115-24.

Motzer R.J., Hutson T.E., Tomczak P. et al. Sunitinib versus Interferon alfa in metastatic renal-cell carcinoma. N Engl J Med 2007;356:115-24.

4. Motzer R.J., Huston T.E., Tomczak P. et al. Overall survival and updated results for sunitinib compared with interferon alfa in patients with metastatic renal-cell carcinoma. J Clin Oncol 2009;27:3584-90.

Motzer R.J., Huston T.E., Tomczak P. et al. Overall survival and updated results for sunitinib compared with interferon alfa in patients with metastatic renal-cell carcinoma. J Clin Oncol 2009;27:3584-90.

5. Motzer R.J., Rini B.I., Bukowski R.M. et al. Sunitinib in patients with metastatic renal cell carcinoma. JAMA 2006;295:2516-24.

Motzer R.J., Rini B.I., Bukowski R.M. et al. Sunitinib in patients with metastatic renal cell carcinoma. JAMA 2006;295:2516-24.

6. Parkin D.M., Bray F., Ferlay J. et al. Global Cancer Statistics, 2002. CA Cancer J Clin 2005;55:74-108.

Parkin D.M., Bray F., Ferlay J. et al. Global Cancer Statistics, 2002. CA Cancer J Clin 2005;55:74-108.

7. Kollmannsberger C., Soulieres D., Wong R. et al. Sunitinib therapy for metastatic renall cell carcinoma: recommendations for management of side effects. Can Ural Assoc J 2007;1:41-54.

Kollmannsberger C., Soulieres D., Wong R. et al. Sunitinib therapy for metastatic renall cell carcinoma: recommendations for management of side effects. Can Ural Assoc J 2007;1:41-54.